MedTrace Logo

Enhanced Recovery After Urogynaecological Surgery - Early Urinary Catheter Removal in an Asian Population

NCT07768878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2026-08-17

No results posted yet for this study

Summary

It is estimated that more than 50% of parous women are impaired by pelvic organ prolapse (POP). By 85 years of age, 11-19% of women will have undergone at least one operation for POP, and this is expected to increase due to Singapore's aging population. Currently, locally, patients remain inpatient for minimum 2 days post-operatively as removal of indwelling catheter (IDC) and trial of void is done on 1st to 2nd post operative day. However, there is a trend towards same-day surgery and same-day removal of IDC in western populations with good success (ranging 40-90% success). Inpatient stays can be prolonged due to voiding dysfunction after removal of IDC which require reinsertion of IDC and another trial of void the next day. Thus, the investigators seek to investigate if removal of IDC is feasible on first post-operative day. If successful, this will change current local practice, improve time to ambulation and reduce length of hospital stay and costs.

Early catheter removal after pelvic organ prolapse surgery reduces time to spontaneous void, post-void residual volume, length of admission, and pain score.

Aims:

1. To investigate if early catheter removal reduces time to spontaneous void and post-void residual urine volume or risks of urinary retention
2. To determine if early catheter removal results in earlier ambulation and shorter length of admission.
3. To determine if patient satisfaction is improved with early catheter removal.

Conditions

  • Postoperative Complications

Interventions

OTHER

Early indwelling catheter removal

Early indwelling catheter and vaginal pack removal on same day of operation, 6 hours post-operatively

Sponsors & Collaborators

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Xinyi Li, MBBS, MRCOG · KK Women's and Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-10-09
Completion
2025-10-23

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07768878 on ClinicalTrials.gov